A new 'off-the-shelf' vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these deadly ...

According to them, the vaccine can safely and effectively train the immune system to recognise and fight cancer-driving ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.

In August 2025, Seagen announced a studies how well tucatinib works for solid tumors that make either more HER2 or a ...

DelveInsight's Interleukin-23 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report ...

An experimental vaccine targeting one of the most common genetic drivers of hard-to-treat pancreatic and colorectal cancers prevented their recurrence, raising hopes for an "off the shelf" treatment ...